Clinical effect of She medical Shiliangcha compound prescription in treating obesity complicated with OSAHS
10.3969/j.issn.1673-9701.2025.04.016
- VernacularTitle:畲药食凉茶组方治疗肥胖合并OSAHS的临床疗效
- Author:
Xingzu JI
1
;
Minhua ZHOU
1
Author Information
1. 浙江中医药大学附属丽水中医院呼吸与危重症医学科,浙江丽水 323000
- Publication Type:Journal Article
- Keywords:
She medical Shiliangcha compound prescription;
Obstructive sleep apnea hypopnea syndrome;
Obesity;
Syndrome of internal exuberance of phlegm-damp;
Clinical effect;
Safety
- From:
China Modern Doctor
2025;63(4):66-68,76
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy and safety of She medical Shiliangcha compound prescription in treating obesity with syndrome of internal exuberance of phlegm-damp complicated with obstructive sleep apnea hypopnea syndrome(OSAHS).Methods A total of 90 patients with obesity with syndrome of internal exuberance of phlegm-damp complicated with OSAHS diagnosed and treated in Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University from January 2023 to February 2024 were selected and divided into control group and treatment group according to random number table method,with 45 cases in each group.Patients in control group received continuous positive airway pressure(CPAP)with non-invasive ventilator,and patients in treatment group was treated with She medical Shiliangcha compound prescription on the basis of control group.Both groups of patients were treated for 3 months.Body mass index(BMI),Epworth sleeping scale(ESS)score,sleep apnea index and adverse reactions were compared between two groups.Results After treatment,ESS score,BMI,apnea-hypopnea index(AHI)in two groups were significantly lower than before treatment,and minimum blood oxygen saturation(LSaO2)was significantly higher than before treatment(P＜0.05).ESS score,BMI and AHI in treatment group were significantly lower than those in control group,and LSaO2 was significantly higher than that in control group(P＜0.05).The incidence of adverse reactions in treatment group was significantly lower than that in control group(x2=6.429,P=0.011).Conclusion The She medical Shiliangcha compound prescription has a definite therapeutic effect on the treatment of obesity with syndrome of internal exuberance of phlegm-damp complicated with OSAHS.It can reduce BMI and ESS score,improve sleep apnea parameters,and reduce adverse reactions caused by non-invasive ventilator assisted ventilation.
